Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8371575rdf:typepubmed:Citationlld:pubmed
pubmed-article:8371575lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:8371575lifeskim:mentionsumls-concept:C0023467lld:lifeskim
pubmed-article:8371575lifeskim:mentionsumls-concept:C0023545lld:lifeskim
pubmed-article:8371575lifeskim:mentionsumls-concept:C0598312lld:lifeskim
pubmed-article:8371575lifeskim:mentionsumls-concept:C0231491lld:lifeskim
pubmed-article:8371575lifeskim:mentionsumls-concept:C0079411lld:lifeskim
pubmed-article:8371575lifeskim:mentionsumls-concept:C1515021lld:lifeskim
pubmed-article:8371575lifeskim:mentionsumls-concept:C0128640lld:lifeskim
pubmed-article:8371575pubmed:issue9lld:pubmed
pubmed-article:8371575pubmed:dateCreated1993-10-12lld:pubmed
pubmed-article:8371575pubmed:abstractTextWe have studied the actions of inhibitors of leukotriene generation on DNA synthesis (measured by 3H-thymidine incorporation) in blast cells from patients with acute myeloid leukaemia (AML). Cells from a subset only of these patients were sensitive to MK 886, a potent selective inhibitor of leukotriene synthesis. By contrast, DNA replication in cells from all of the patients was inhibited by nordihydroguiaretic acid (NDGA), a leukotriene synthesis inhibitor of lower selectivity. DNA synthesis in normal bone marrow cells and phytohaemagglutinin-stimulated lymphocytes was sensitive to NDGA but not to MK 886. The data suggest that NDGA inhibits DNA replication by a mechanism other than the abolition of leukotriene biosynthesis, but that DNA synthesis in a subset of AML cells may be dependent on the generation of lipoxygenase products, as indicated by sensitivity to MK 886.lld:pubmed
pubmed-article:8371575pubmed:languageenglld:pubmed
pubmed-article:8371575pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8371575pubmed:citationSubsetIMlld:pubmed
pubmed-article:8371575pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8371575pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8371575pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8371575pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8371575pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8371575pubmed:statusMEDLINElld:pubmed
pubmed-article:8371575pubmed:monthSeplld:pubmed
pubmed-article:8371575pubmed:issn0145-2126lld:pubmed
pubmed-article:8371575pubmed:authorpubmed-author:KhanM AMAlld:pubmed
pubmed-article:8371575pubmed:authorpubmed-author:MehtaAAlld:pubmed
pubmed-article:8371575pubmed:authorpubmed-author:HoffbrandA...lld:pubmed
pubmed-article:8371575pubmed:authorpubmed-author:WrightFFlld:pubmed
pubmed-article:8371575pubmed:authorpubmed-author:Wickremasingh...lld:pubmed
pubmed-article:8371575pubmed:authorpubmed-author:TahamiFFlld:pubmed
pubmed-article:8371575pubmed:issnTypePrintlld:pubmed
pubmed-article:8371575pubmed:volume17lld:pubmed
pubmed-article:8371575pubmed:ownerNLMlld:pubmed
pubmed-article:8371575pubmed:authorsCompleteYlld:pubmed
pubmed-article:8371575pubmed:pagination759-62lld:pubmed
pubmed-article:8371575pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:8371575pubmed:meshHeadingpubmed-meshheading:8371575-...lld:pubmed
pubmed-article:8371575pubmed:meshHeadingpubmed-meshheading:8371575-...lld:pubmed
pubmed-article:8371575pubmed:meshHeadingpubmed-meshheading:8371575-...lld:pubmed
pubmed-article:8371575pubmed:meshHeadingpubmed-meshheading:8371575-...lld:pubmed
pubmed-article:8371575pubmed:meshHeadingpubmed-meshheading:8371575-...lld:pubmed
pubmed-article:8371575pubmed:meshHeadingpubmed-meshheading:8371575-...lld:pubmed
pubmed-article:8371575pubmed:meshHeadingpubmed-meshheading:8371575-...lld:pubmed
pubmed-article:8371575pubmed:meshHeadingpubmed-meshheading:8371575-...lld:pubmed
pubmed-article:8371575pubmed:meshHeadingpubmed-meshheading:8371575-...lld:pubmed
pubmed-article:8371575pubmed:meshHeadingpubmed-meshheading:8371575-...lld:pubmed
pubmed-article:8371575pubmed:meshHeadingpubmed-meshheading:8371575-...lld:pubmed
pubmed-article:8371575pubmed:meshHeadingpubmed-meshheading:8371575-...lld:pubmed
pubmed-article:8371575pubmed:year1993lld:pubmed
pubmed-article:8371575pubmed:articleTitleMK 886, an antagonist of leukotriene generation, inhibits DNA synthesis in a subset of acute myeloid leukaemia cells.lld:pubmed
pubmed-article:8371575pubmed:affiliationDepartment of Haematology, Royal Free Hospital Medical School, London, U.K.lld:pubmed
pubmed-article:8371575pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8371575pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed